Skip to content

Net margin at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
9.6%+5.8pp
Opko Health logo
Opko HealthOPK
-36.6%-44.8pp
Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-49.9%-24.9pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
-4.6%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

Based on trailing twelve months.

The official record: SIGA Technologies’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's net margin?
SIGA Technologies (SIGA) reported net margin of 43.2% in Q3 2025.
How has SIGA Technologies's net margin changed year-over-year?
SIGA Technologies's net margin decreased by 12.4% year-over-year, from 49.3% to 43.2%.
What is the long-term trend for SIGA Technologies's net margin?
Over 4 years (2020 to 2024), SIGA Technologies's net margin has grown at a -1.4% compound annual growth rate (CAGR), from 45.1% to 42.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.